Article
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system
15 Jan 2018
Abstract excerpt
Abstract First identified as the etiological agent behind Acquired Immunodeficiency Syndrome (AIDS) in the early 1980s, HIV-1 has continued to spread into a global pandemic and major public health concern. Despite the success of antiretroviral therapy at reducing HIV-1 viremia and preventing the dramatic CD4+ T-cell collapse, infected individuals remain HIV positive for life. Unfortunately, it is increasingly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.